The invention relates to compounds of formula:
1
These compounds show affinity for the bradykinin receptors with selectivity towards the B
1
receptors; they may be used for the preparation of medicinal products intended for treating or preventing inflammation pathologies and persistent or chronic inflammatory diseases.
本发明涉及以下化合物的公式:1
这些化合物表现出对
缓激肽受体的亲和力,具有选择性作用于B1受体;可以用于制备用于治疗或预防炎症病理和持续或慢性炎症性疾病的药物。